Pediatric Dermatology

Latest News


CME Content


National report - Researchers at Dartmouth Medical Schoolhave for the first time established an association betweeninfection with certain strains of human papillomavirus (HPV) andincreased risk for developing squamous cell carcinoma (SCC).

Botox reaches India

Bangalore, India - U.S. pharmaceutical company Allergan hasobtained a license from the Drugs Controller General of India tointroduce Botox in India.

Washington - A human papilloma virus (HPV) vaccine, based onnoninfectious virus-like particles, could be on the market as earlyas this summer, according to John Schiller, Ph.D., section chief,laboratory of cellular oncology, National Cancer Institute,Bethesda, Md.

Cultural concerns

The Chinese culture exerts a profound impact on a variety of medical decisions, including face transplants, sources say.

San Francisco - Preventive measures taken before radiation orchemotherapy treatments have helped reduce many of the bothersomeoral side effects, an expert tells Dermatology Times.

Las Vegas - The new wound healing product Biafine (OrthoNeutrogena), gaining popularity among radiation oncologists for the treatment of radiation dermatitis, also offers an innovative option for dermatologists in treating problems ranging from sunburn to superficial wounds, according to Diane Berson, M.D., speaking at the annual meeting of the American Society of Cosmetic Dermatology and Aesthetic Surgery here.

New York - Treating pediatric atopic dermatitis (AD)effectively can involve both newer treatments, such as calcineurininhibitors and TNF agonists, as well as new twists on existingtreatments, according to Lisa A. Beck, M.D.

National report - Vascular birthmarks in the pediatricpopulation can create a wide array of questions and concerns forphysicians and parents, says Ilona Frieden, M.D., of the departmentof dermatology, University of California, San Francisco.

What is your take on antibiotic resistance? How do you respond to statements that dermatologists have used antibiotics too indiscriminately, compounding resistance problems? Are we, as a specialty, doing something bad for medicine?

I would propose a temporary partial moratorium on splashyinfomercials and interviews with magazines, whose readers are moreinterested in beauty than in improved function of the skin. ... Iam only asking that we calm down the rhetoric about the cosmeticportion of our practices and emphasize other aspects instead.